119 related articles for article (PubMed ID: 425440)
1. [Side-effects of the donator of sulfhydryl groups, unithiol].
Dubinskiĭ AA; Guĭda PP
Vrach Delo; 1979 Feb; (2):68-71. PubMed ID: 425440
[No Abstract] [Full Text] [Related]
2. [Unithiol in treatment of circumscribed forms of scleroderma].
Kapralov IK
Vestn Dermatol Venerol; 1976 Nov; (11):72-5. PubMed ID: 1023640
[No Abstract] [Full Text] [Related]
3. [Effect of unithiol on collagen metabolism in systemic scleroderma].
Pasieshvili LM
Vopr Revm; 1980; (1):57-8. PubMed ID: 7385751
[No Abstract] [Full Text] [Related]
4. [Morphological changes in the skin in scleroderma in the process of treatment with unithiol].
Dubinskiĭ AA; Tseraidis GS; Guĭda PP; Petrusenko EA; Babykina EA
Vrach Delo; 1978 Oct; (10):112-4. PubMed ID: 716343
[No Abstract] [Full Text] [Related]
5. [Treatment of scleroderma with unithiol].
Dubinskiĭ AA; Guida PP
Vopr Revm; 1974; (2):54-8. PubMed ID: 4369704
[No Abstract] [Full Text] [Related]
6. [Experimental study of the anti-arrhythmia action of unithiol].
Starshinova AE
Farmakol Toksikol; 1975; 38(2):168-70. PubMed ID: 1227881
[TBL] [Abstract][Full Text] [Related]
7. [Unithiol in the treatment of dermatoses].
Tsyganok SS
Vestn Dermatol Venerol; 1978 Sep; (9):67-9. PubMed ID: 360679
[No Abstract] [Full Text] [Related]
8. [Piascledine in the treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1974; 61(4):525-7. PubMed ID: 4849404
[No Abstract] [Full Text] [Related]
9. [Therapeutic efficacy of unithiol in Buschke's scleredema].
Guĭda PP; Dubinskiĭ AA
Vrach Delo; 1983 Aug; (8):36-8. PubMed ID: 6636679
[No Abstract] [Full Text] [Related]
10. [Unithiol and mecaptid as antidotes in poisoning with arsenic-containing substances].
Miziukova IG; Petrun'kin VE
Vrach Delo; 1974 Feb; (2):126-9. PubMed ID: 4468608
[No Abstract] [Full Text] [Related]
11. [General and local hormonal therapy in scleroderma].
Dobrescu A; Petrescu Z; Martinescu E; Costinescu M; Vasilca A; Popescu E; Rotaru L; Tăranu T; Pavelescu DM
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):145-9. PubMed ID: 3393746
[No Abstract] [Full Text] [Related]
12. [Effect of piascledine treatment of scleroderma].
Szczepański A; Dabrowska H; Moskalewska K
Przegl Dermatol; 1975; 62(4):555-8. PubMed ID: 1162105
[No Abstract] [Full Text] [Related]
13. [Use of sulfhydryl-group donors in the complex treatment of diabetic ketoacidosis].
Zelinskiĭ BA; Goncharov LI; Gamarnik LV
Ter Arkh; 1981; 53(4):132-3. PubMed ID: 6789488
[No Abstract] [Full Text] [Related]
14. [Correction of sulfhydryl group level in patients with diabetes mellitus].
Sedov KR; Bobovskaia LG
Klin Med (Mosk); 1978 Aug; 56(8):61-5. PubMed ID: 703215
[No Abstract] [Full Text] [Related]
15. Salazopyrin (azulfidine) treatment in scleroderma.
Dover N
Isr J Med Sci; 1971 Nov; 7(11):1301-3. PubMed ID: 4400695
[No Abstract] [Full Text] [Related]
16. Stimulating circulation to end stasis in scleroderma.
Yuan X; Li JD; Chen WJ; Li ZS; Zhu HT; Liu JW; Zhu MJ
Chin Med J (Engl); 1981 Feb; 94(2):85-93. PubMed ID: 6786844
[No Abstract] [Full Text] [Related]
17. Biological behavior and metabolic fate of the BAL analogues DMSA and DMPS.
McGown EL; Tillotson JA; Knudsen JJ; Dumlao CR
Proc West Pharmacol Soc; 1984; 27():169-76. PubMed ID: 6093126
[No Abstract] [Full Text] [Related]
18. [Therapeutic effectiveness of ultrasonics and lidase phonophoresis in various forms of scleroderma].
Didenko IG
Vestn Dermatol Venerol; 1978 Jun; (6):76-9. PubMed ID: 354249
[No Abstract] [Full Text] [Related]
19. [Madecassol in the treatment of scleroderma (preliminary study)].
Szczepański A; Dabrowska H; Blaszczyk M
Przegl Dermatol; 1974; 61(5):701-3. PubMed ID: 4419170
[No Abstract] [Full Text] [Related]
20. PUVA treatment in sclerodermatoid spectrum of dermatologic diseases: our initial experience.
Baum S; Pavlotsky F; Shpiro D; Trau H
Isr Med Assoc J; 2004 Sep; 6(9):563-4. PubMed ID: 15373320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
